Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beer

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
Nature Communications|October 19, 2013
Reconstructing targetable pathways in lung cancer by integrating diverse omics dataO Alejandro Balbin, John R Prensner, Anirban Sahu, et al.
Oncotarget|July 1, 2016
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomasDaysha Ferrer-Torres, Derek J Nancarrow, Rork Kuick, et al.
Gut|October 8, 2020
Multiplexed endoscopic imaging of Barrett's neoplasia using targeted fluorescent heptapeptides in a phase 1 proof-of-concept studyJing Chen, Yang Jiang, Tse-Shao Chang, et al.
Genes, Chromosomes & Cancer|December 2, 2005
Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinomaLin Lin, Zhuwen Wang, Michael S Prescott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinomaGuoan Chen, So Hee Kim, Amanda N King, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Oncotarget|July 4, 2015
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancerMoloy T Goswami, Guoan Chen, Balabhadrapatruni V S K Chakravarthi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 9, 2012
Characterization of vitamin D receptor (VDR) in lung adenocarcinomaSo Hee Kim, Guoan Chen, Amanda N King, et al.
Oncogene|March 1, 2005
Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cellsFederico A Steiner, Julie A Hong, Maria R Fischette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinomaErnest Nadal, Guoan Chen, John R Prensner, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
Nature Communications|October 19, 2013
Reconstructing targetable pathways in lung cancer by integrating diverse omics dataO Alejandro Balbin, John R Prensner, Anirban Sahu, et al.
Oncotarget|July 1, 2016
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomasDaysha Ferrer-Torres, Derek J Nancarrow, Rork Kuick, et al.
Gut|October 8, 2020
Multiplexed endoscopic imaging of Barrett's neoplasia using targeted fluorescent heptapeptides in a phase 1 proof-of-concept studyJing Chen, Yang Jiang, Tse-Shao Chang, et al.
Genes, Chromosomes & Cancer|December 2, 2005
Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinomaLin Lin, Zhuwen Wang, Michael S Prescott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinomaGuoan Chen, So Hee Kim, Amanda N King, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Oncotarget|July 4, 2015
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancerMoloy T Goswami, Guoan Chen, Balabhadrapatruni V S K Chakravarthi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 9, 2012
Characterization of vitamin D receptor (VDR) in lung adenocarcinomaSo Hee Kim, Guoan Chen, Amanda N King, et al.
Oncogene|March 1, 2005
Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cellsFederico A Steiner, Julie A Hong, Maria R Fischette, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinomaErnest Nadal, Guoan Chen, John R Prensner, et al.
Pageof 33